MRFR Year End Sale
Seasonal Affective Disorder Market Research Report - Global Forecast till 2030

Seasonal Affective Disorder Market information: by type (fall and winter SAD, and others), by diagnosis (physical exam, lab tests, and others), by treatment (light therapy, medications, and others), by end user- global forecast till 2030

ID: MRFR/Pharma/2779-HCR | December 2022 | Region: Global | 78 Pages         

Seasonal Affective Disorder Market

The Seasonal Affective Disorder Market is to reach USD 1.1 Billion by 2030 at CAGR of 4.5%.

Segmentation

By type fall and winter SAD and others
By diagnosis physical exam lab tests and others
By treatment light therapy medications and others
By end-user hospitals and clinics

Key Players

  • AbbVie
  • Allergan Republic of Ireland
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd. In Switzerland
  • Henry Schein

Drivers

  • Rising number of people affected by the seasonal affective disorder
Speak to Analyst Request a Free Sample

Seasonal Affective Disorder Market Overview


The Seasonal Affective Disorder Market is estimated to reach USD 1.1 Billion by 2030 at CAGR of 4.5% during the forecast period. Seasonal Affective Disorder is a mental disorder that affects people mentally in a particular season. This disorder mostly affects the person in the winter, but there is no clarity on that as it can affect the person in summer. It affects the person in a particular season. It is mostly found in women and women between the ages of 15 to 25 who suffer from this disorder. The people who live far from the equator also face this disorder. The key symptoms of this disorder are increased appetite, hopelessness, social withdrawal and instant weight gain. The risks attached to these disorders are depressive disorder, bipolar I disorder and bipolar II disorder and others. Many antipsychotic medications areas used as a short term treatment for the disorder having the symptoms like hallucination, delusion and others.


The increasing prevalence and increasing awareness of this disorder are propelling the market. The market will experience a high growth rate in the forecast period as the young generation is not following any fitness tricks. Due to several pressures such as peer pressure, work pressure and others, the market will hold the business globally and establish its name over the world. The Seasonal Affective Disorder Market Outlook is taken into account to improve the situations and create a new outlook for the new key players.


Covid-19 analysis 


In the spread of the novel coronavirus, many markets and businesses get shut down due to less profit and government order. Government orders to shut down every market harshly affected the market value. The shutdown affected every business owner mentally, and some people went through many mental disorders in the pandemic. However, pandemics affected people's mental state, but the Seasonal Affective Disorder Market got into highlight due to that. The market got positively affected in the COVId 19.


Chief Factors Existing In The Market  



  • Key drivers


the improvement in the healthcare sector and the rising number of people affected by the seasonal affective disorder are key drivers for market growth. Due to several organizations' lifestyle changes and work pressure, mental peace is getting affected, also pushing the market forward. During the pandemic, the cases increased as everyone had to stay at home, which impacted the mental pressure boosting the Seasonal Affective Disorder Market Growth. The increasing number of people visiting the physician is due to Seasonal Affective Disorder is propelling the market growth. Lack of exercise and people not moving out of the house is also driving factor for the market. Continuous addition of new technology and new medication for the disorder also makes the market grow. Devices included in the treatment of SAD are dawn stimulation, lightboxes and desk lamps. The Seasonal Affective Disorder Market Trends are also developing the marketplace.



  • Market challenges


The less counseling and few doctors' availabilities for the treatment of mental disorders is a market challenge for the market. The market is also facing several other challenges. People are getting aware of the medications and diseases, and adapting different physical activities to overcome the issues are challenging the market for further growth.



  • Market opportunities


An increasing number of patients is one of the key opportunities for the market. The young generation is getting used to many narcotic things, and the lifestyle of eating outside is also forming ample opportunity for the Seasonal Affective Disorder Market Value. These opportunities will attract new market players to invest and improve the marketplace globally.



  • Market restraints


The side effects caused due to the seasonal affective disorder medications are hindering the market from growth. The medication didn't suit everybody and caused many issues. People getting aware of the issues and changing the lifestyle from no exercise to exercise is restraining the market from growth. Many people are facing side effects due to the dosage of the drug bupropion. The image needs to be reduced for people facing side effects.


Cumulative Evaluation Of The Market  


The cumulative evaluation of the market shows the position of the market in the forecast period. It shows the market condition and the factors affecting the market positively and negatively—the market's rate of success and loss in the recent scenario depicted in the report. Drivers and opportunities of the market improve the market growth, and due to that, the market situation changes. Restrains and challenges pull the market backward and affect the forecast period's market value. It also shows the COVID 19 effect in the market. Due to the present situation of the market, it will absorb more growth toward the upcoming times.


Seasonal Affective Disorder Market Segmentation 


The Seasonal Affective Disorder Market has been segmented by type, diagnosis, treatment and end-user. All the market segments will highlight the market in the forecast period. 



  • By type


The Seasonal Affective Disorder Market is classified into fall, winter SAD, and others based on the type. Each segment is making the market grow, and every segment will showcase high growth in the forecast period.



  • By diagnosis


The Seasonal Affective Disorder Market is divided into physical exams, lab tests and others. The lab segment is again classified into complete blood count, thyroid blood test and others.



  • By treatment


Light therapy, medication, psychotherapy, counseling and others are the prominent variables of the treatment segment. Medication consists of antidepressants and others. Antidepressants are again segmented into reuptake inhibitors (SSRIs) and others. Psychotherapy is bifurcated into behavioral therapy, body psychotherapy, cognitive analytical therapy, gestalt therapy, existential psychotherapy, etc.



  • By end-user


The market is divided into academic institutes, medical research centers, hospitals and clinics, and others based on the end-user. Each segment of the market will push the market forward, and it will be included in the Seasonal Affective Disorder Market Size.


Seasonal Affective Disorder Market Regional analysis 


The Seasonal Affective Disorder Market is analyzed in North America, Asia Pacific, Europe and other parts. As America holds the largest market share globally, the market is expected to showcase prominent growth in the North American region. In the region approx, 5% of people are suffering from seasonal depression. The adaptation of the lifestyle change is in the region is another factor for the market growth. The increasing awareness about various disorders in brazil and South America is also helping the market grow. 2% of the population in northern Europe is experiencing depression, leading to seasonal affective disorder. Other European countries are growing significantly. The Asia Pacific region holds a 0.9% market share due to less awareness. However, in other regions, the market is getting popular due to changes in lifestyle, health facilities, availability of treatments etc. are improving the Seasonal Affective Disorder Market Share. The middle and African region is showcasing slow growth due to the prevalence rate, less awareness and fewer facilities.


Competitive Intensity Within The Industry   


The competitive intensity of the market depicts the details of the players who are investing in the market. Several strategies and new ideas added to the market segmentation are mentioned in the market. Several key market players are investing in the market and gaining a good profit. The increases in the competitive landscape and geography of the Seasonal Affective Disorder Market will automatically improve the market growth. the market players who are investing in the market are 



  • AbbVie Inc. In the US

  • Allergan Republic of Ireland

  • Bayer AG in Germany

  • Bristol-Myers Squibb Company in the US

  • F. Hoffmann-La Roche Ltd. In Switzerland

  • Henry Schein, Inc. In USP

  • Pfizer Inc. In US 

  • others


Recent development  



  • The recent research by the national alliance for mental illness says over 20 million Americans are battling depression. Its shows the patient's number gets high in winters.

  • The Senate unanimously made the sunshine protection act on Tuesday, which would end the practice of changing them twice a year by 2023 November.


Report Overview 


The Seasonal Affective Disorder Market report depicts the overall information about the market situation. It shows the overall impact of the market globally. The overall development and the market condition are showcased in the market. Many methods and research are done to gather the needed information on the market. The report involves strategies and ideas that will increase the market value in the forecast period. According to Market Analysis, the factors will impact the market. The Seasonal Affective Disorder Market consists of key factors, COVID analysis, restraints and challenges impacting the market growth, key players investing in the market, and the recent developments of the market that are improving the CAGR of the market.


Key industrial segments 


By type



  • fall 

  • winter SAD

  • others


By diagnosis



  • physical exam

  • lab tests 

  • others


By Treatment



By End-User



  • academic institutes

  • medical research centers

  • hospitals 

  • clinics 

  • others



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 1.1 Billion : 2030
  CAGR   4.5% : 2030
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By type, By diagnosis,By treatment , By end-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   AbbVie Inc. In the US,Allergan Republic of Ireland,Bayer AG in Germany,Bristol-Myers Squibb Company in the US,F. Hoffmann-La Roche Ltd. In Switzerland,Henry Schein, Inc. In USP,Pfizer Inc. In US ,others
  Key Market Opportunities   increasing number of patients is one of the key opportunities for the market.
  Key Market Drivers   rising number of people affected by the seasonal affective disorder


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

seasonal affective disorder market valuation would be USD 1.1 Billion by 2030.

seasonal affective disorder market CAGR would be 4.5% during the forecast period.

AbbVie Inc. In the US,Allergan Republic of Ireland,Bayer AG in Germany,Bristol-Myers Squibb Company in the US,F. Hoffmann-La Roche Ltd. In Switzerland,Henry Schein, Inc. In USP,Pfizer Inc. In US ,others 

The treatment types included in the seasonal affective disorder market report are medications, psychotherapy, counselling, light therapy (phototherapy), and others.

The Americas fetches the maximum seasonal affective disorder market revenue.

The diagnosis segment of the seasonal affective disorder market report includes psychological evaluation, physical exam, lab tests, and others.